PUK19 - COST-UTILITY OF SUCROFERRIC OXYHYDROXIDE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING DIALYSIS IN CANADA
Abstract
Authors
F. Mills H. Qureshi G. Banks G. Haitsma S. Walpen P. Vrouchou